Pursuant to Section 307B.4, Title 25, Oklahoma Statutes, consider convening in executive session to discuss an action relating to litigation against the manufacturers, distributors and retailers of opioids in an effort to hold them accountable for their marketing practices alleged to have caused public nuisance and monetary damages suffered by municipalities, to include considering approving settlements with: (1) Walgreens, (2) CVS, (3) Walmart, (4) Allergan and (5) Teva, and if necessary, take action in open session.

Committee

City Council

Introduced

March 6, 2023

On agenda

March 28, 2023